Dr. Admirand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3445 Executive Center Dr
Suite 250
Austin, TX 78731Phone+1 512-579-4000Fax+1 512-439-2814
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 2003 - 2004
- University of Utah HealthResidency, Pathology-Anatomic and Clinical, 1998 - 2002
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1998
Certifications & Licensure
- NM State Medical License 2012 - 2027
- ID State Medical License 2019 - 2026
- TN State Medical License 2011 - 2026
- CA State Medical License 2011 - 2025
- LA State Medical License 2012 - 2025
- NV State Medical License 2017 - 2025
- OH State Medical License 2012 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematopathology
- Join now to see all
Publications & Presentations
PubMed
- 77 citationsMCL-1 expression in B-cell non-Hodgkin’s lymphomasJeong Hee Cho-Vega, George Z. Rassidakis, Joan H. Admirand, Mauricio P. Oyarzo, Preetha Ramalingam
Human Pathology. 2004-09-01 - 16 citationsPrimary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature.Brett H. Keeling, Alde Carlo P. Gavino, Joan H. Admirand, Anthony C. Soldano
Journal of Cutaneous Pathology. 2017-11-01 - 103 citationsFollicular dendritic cell sarcoma: a report of 14 cases and a review of the literature.Andres O. Soriano, Michael A. Thompson, Joan H. Admirand, Luis Fayad, Alma Rodriguez
American Journal of Hematology. 2007-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: